메뉴 건너뛰기




Volumn 317, Issue 1, 2006, Pages 54-60

High throughput microsomal stability assay for insoluble compounds

Author keywords

Automation; High throughput; LC MS; Metabolism; Robotics; Solubility; stability

Indexed keywords

ALBENDAZOLE; ASTEMIZOLE; ATENOLOL; BIFONAZOLE; BUPIVACAINE; CHLORPROMAZINE; CIMETIDINE; DANAZOL; DEBRISOQUINE; FELODIPINE; ISOXICAM; KETOCONAZOLE; LABETALOL; MICONAZOLE; NORFLOXACIN; NORTRIPTYLINE; OFLOXACIN; PHENYTOIN; PIROXICAM; PROBENECID; PROMETHAZINE; PROPRANOLOL; QUINIDINE; SOLVENT; SULFAMETHOXAZOLE; TERBUTALINE; TERFENADINE; THYMIDINE; TRIFLUPROMAZINE; UNINDEXED DRUG;

EID: 33744994966     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.03.007     Document Type: Article
Times cited : (66)

References (46)
  • 1
    • 0842332512 scopus 로고    scopus 로고
    • High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism
    • Ansede J.H., and Thakker D.R. High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism. J. Pharmaceut. Sci. 93 (2004) 239-255
    • (2004) J. Pharmaceut. Sci. , vol.93 , pp. 239-255
    • Ansede, J.H.1    Thakker, D.R.2
  • 3
    • 0033800945 scopus 로고    scopus 로고
    • Rapid assessment of drug metabolism in the drug discovery process
    • Bertrand M., et al. Rapid assessment of drug metabolism in the drug discovery process. Eur. J. Pharmaceut. Sci. 11 (2000) S61-S72
    • (2000) Eur. J. Pharmaceut. Sci. , vol.11
    • Bertrand, M.1
  • 4
    • 0345490845 scopus 로고    scopus 로고
    • Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450
    • Busby Jr. W.F., et al. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug Metabol. Disposition: Biol. Fate Chem. 27 (1999) 246-249
    • (1999) Drug Metabol. Disposition: Biol. Fate Chem. , vol.27 , pp. 246-249
    • Busby Jr., W.F.1
  • 5
    • 0033019372 scopus 로고    scopus 로고
    • High throughput liquid chromatography-mass spectrometry assessment of the metabolic activity of commercially available hepatocytes from 96-well plates
    • Caldwell G.W., et al. High throughput liquid chromatography-mass spectrometry assessment of the metabolic activity of commercially available hepatocytes from 96-well plates. Combinat. Chem. High Throughput Screen. 2 (1999) 39-51
    • (1999) Combinat. Chem. High Throughput Screen. , vol.2 , pp. 39-51
    • Caldwell, G.W.1
  • 6
    • 0035416240 scopus 로고    scopus 로고
    • Prediction of pharmacokinetic properties using experimental approaches during early drug discovery
    • Chaturvedi P.R., et al. Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. Curr. Opin. Chem. Biol. 5 (2001) 452-463
    • (2001) Curr. Opin. Chem. Biol. , vol.5 , pp. 452-463
    • Chaturvedi, P.R.1
  • 7
    • 0031940804 scopus 로고    scopus 로고
    • Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes
    • Chauret N., et al. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metabol. Disposition 26 (1998) 1-4
    • (1998) Drug Metabol. Disposition , vol.26 , pp. 1-4
    • Chauret, N.1
  • 8
    • 0037523454 scopus 로고    scopus 로고
    • Profiling drug-like properties in discovery research
    • Di L., and Kerns E.H. Profiling drug-like properties in discovery research. Curr. Opin. Chem. Biol. 7 (2003) 402-408
    • (2003) Curr. Opin. Chem. Biol. , vol.7 , pp. 402-408
    • Di, L.1    Kerns, E.H.2
  • 9
    • 21444435047 scopus 로고    scopus 로고
    • Application of pharmaceutical profiling assays for optimization of drug-like properties
    • Di L., and Kerns E.H. Application of pharmaceutical profiling assays for optimization of drug-like properties. Curr. Opin. Drug Discovery Dev. 8 (2005) 495-504
    • (2005) Curr. Opin. Drug Discovery Dev. , vol.8 , pp. 495-504
    • Di, L.1    Kerns, E.H.2
  • 10
    • 33744988691 scopus 로고    scopus 로고
    • Di, L., Kerns, E.H., in press. Biological assay challenges from solubility: strategies for bioassay optimization. Drug Discovery Today.
  • 11
    • 2142722247 scopus 로고    scopus 로고
    • Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates
    • Di L., et al. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates. J. Biomol. Screen 8 (2003) 453-462
    • (2003) J. Biomol. Screen , vol.8 , pp. 453-462
    • Di, L.1
  • 12
    • 2642513322 scopus 로고    scopus 로고
    • Experimental design on single-time-point high-throughput microsomal stability assay
    • Di L., et al. Experimental design on single-time-point high-throughput microsomal stability assay. J. Pharmaceut. Sci. 93 (2004) 1537-1544
    • (2004) J. Pharmaceut. Sci. , vol.93 , pp. 1537-1544
    • Di, L.1
  • 14
    • 0034677966 scopus 로고    scopus 로고
    • Drug discovery: a historical perspective
    • Drews J.u.r. Drug discovery: a historical perspective. Science 287 (2000) 1960-1964
    • (2000) Science , vol.287 , pp. 1960-1964
    • Drews, J.u.r.1
  • 15
    • 0035146956 scopus 로고    scopus 로고
    • Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes
    • Easterbrook J., et al. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metab. Dispos. 29 (2001) 141-144
    • (2001) Drug Metab. Dispos. , vol.29 , pp. 141-144
    • Easterbrook, J.1
  • 17
    • 0034283752 scopus 로고    scopus 로고
    • ADME/PK as part of a rational approach to drug discovery
    • Eddershaw P.J., et al. ADME/PK as part of a rational approach to drug discovery. Drug Discovery Today 5 (2000) 409-414
    • (2000) Drug Discovery Today , vol.5 , pp. 409-414
    • Eddershaw, P.J.1
  • 18
    • 0037442651 scopus 로고    scopus 로고
    • Combined electrospray ionization-atmospheric pressure chemical ionization source for use in high-throughput LC-MS applications
    • Gallagher R.T., et al. Combined electrospray ionization-atmospheric pressure chemical ionization source for use in high-throughput LC-MS applications. Anal. Chem. 75 (2003) 973-977
    • (2003) Anal. Chem. , vol.75 , pp. 973-977
    • Gallagher, R.T.1
  • 19
    • 12244263506 scopus 로고    scopus 로고
    • Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities
    • Glomme A., and Dressman J.M.J.B. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J. Pharmaceut. Sci. 94 (2005) 1-16
    • (2005) J. Pharmaceut. Sci. , vol.94 , pp. 1-16
    • Glomme, A.1    Dressman, J.M.J.B.2
  • 20
    • 32944462075 scopus 로고    scopus 로고
    • Automated high-throughput ADME-tox profiling for optimization of preclinical candidate success
    • Herbst J.J., and Dickinson K. Automated high-throughput ADME-tox profiling for optimization of preclinical candidate success. Am. Pharmaceut. Rev. 8 (2005) 96-101
    • (2005) Am. Pharmaceut. Rev. , vol.8 , pp. 96-101
    • Herbst, J.J.1    Dickinson, K.2
  • 21
    • 0031921010 scopus 로고    scopus 로고
    • Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities
    • Hickman D., et al. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab. Dispos. 26 (1998) 207-215
    • (1998) Drug Metab. Dispos. , vol.26 , pp. 207-215
    • Hickman, D.1
  • 22
    • 0035298741 scopus 로고    scopus 로고
    • A high-capacity LC/MS system for the bioanalysis of samples generated from plate-based metabolic screening
    • Janiszewski J.S., et al. A high-capacity LC/MS system for the bioanalysis of samples generated from plate-based metabolic screening. Anal. Chem. 73 (2001) 1495-1501
    • (2001) Anal. Chem. , vol.73 , pp. 1495-1501
    • Janiszewski, J.S.1
  • 23
    • 1542362349 scopus 로고    scopus 로고
    • Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries
    • Jenkins K.M., et al. Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries. J. Pharmaceut. Biomed. Anal. 34 (2004) 989-1004
    • (2004) J. Pharmaceut. Biomed. Anal. , vol.34 , pp. 989-1004
    • Jenkins, K.M.1
  • 24
    • 0030886937 scopus 로고    scopus 로고
    • Managing the drug discovery/development interface
    • Kennedy T. Managing the drug discovery/development interface. Drug Discovery Today 2 (1997) 436-444
    • (1997) Drug Discovery Today , vol.2 , pp. 436-444
    • Kennedy, T.1
  • 25
    • 0035150465 scopus 로고    scopus 로고
    • High throughput physicochemical profiling for drug discovery
    • Kerns E.H. High throughput physicochemical profiling for drug discovery. J. Pharmaceut. Sci. 90 (2001) 1838-1858
    • (2001) J. Pharmaceut. Sci. , vol.90 , pp. 1838-1858
    • Kerns, E.H.1
  • 26
    • 16844373414 scopus 로고    scopus 로고
    • Automation in pharmaceutical profiling
    • Kerns E.H., and Di L. Automation in pharmaceutical profiling. J. Assoc. Lab. Automat. 10 (2005) 114-123
    • (2005) J. Assoc. Lab. Automat. , vol.10 , pp. 114-123
    • Kerns, E.H.1    Di, L.2
  • 27
    • 1642534403 scopus 로고    scopus 로고
    • Integrated high capacity solid phase extraction-MS/MS system for pharmaceutical profiling in drug discovery
    • Kerns E.H., et al. Integrated high capacity solid phase extraction-MS/MS system for pharmaceutical profiling in drug discovery. J. Pharmaceut. Biomed. Anal. 34 (2004) 1-9
    • (2004) J. Pharmaceut. Biomed. Anal. , vol.34 , pp. 1-9
    • Kerns, E.H.1
  • 28
    • 4344645978 scopus 로고    scopus 로고
    • Can the pharmaceutical industry reduce attrition rate?
    • Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rate?. Nat. Rev. Drug Discovery 3 (2004) 711-716
    • (2004) Nat. Rev. Drug Discovery , vol.3 , pp. 711-716
    • Kola, I.1    Landis, J.2
  • 29
    • 0032960474 scopus 로고    scopus 로고
    • Development of an automated mass spectrometry system for the quantitative analysis of liver microsomal incubation samples: a tool for rapid screening of new compounds for metabolic stability
    • Korfmacher W.A., et al. Development of an automated mass spectrometry system for the quantitative analysis of liver microsomal incubation samples: a tool for rapid screening of new compounds for metabolic stability. Rapid Commun. Mass Spectrometry: RCM 13 (1999) 901-907
    • (1999) Rapid Commun. Mass Spectrometry: RCM , vol.13 , pp. 901-907
    • Korfmacher, W.A.1
  • 30
    • 2542505336 scopus 로고    scopus 로고
    • Analysis of microsomal metabolic stability using high-flow-rate extraction coupled to capillary liquid chromatography-mass spectrometry
    • Laven M., et al. Analysis of microsomal metabolic stability using high-flow-rate extraction coupled to capillary liquid chromatography-mass spectrometry. J. Chromatogr. B 806 (2004) 119-126
    • (2004) J. Chromatogr. B , vol.806 , pp. 119-126
    • Laven, M.1
  • 31
    • 8444228180 scopus 로고    scopus 로고
    • Generic three-column parallel LC-MS/MS system for high-throughput in vitro screens
    • Lindqvist A., et al. Generic three-column parallel LC-MS/MS system for high-throughput in vitro screens. J. Chromatogr. A 1058 (2004) 121-126
    • (2004) J. Chromatogr. A , vol.1058 , pp. 121-126
    • Lindqvist, A.1
  • 32
    • 0033049029 scopus 로고    scopus 로고
    • Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler
    • Linget J.-M., and du Vignaud P. Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler. J. Pharmaceut. Biomed. Anal. 19 (1999) 893-901
    • (1999) J. Pharmaceut. Biomed. Anal. , vol.19 , pp. 893-901
    • Linget, J.-M.1    du Vignaud, P.2
  • 33
    • 0002510887 scopus 로고    scopus 로고
    • Avoiding investment in doomed drugs
    • Lipinski C.A. Avoiding investment in doomed drugs. Curr. Drug Discovery (2001) 17-19
    • (2001) Curr. Drug Discovery , pp. 17-19
    • Lipinski, C.A.1
  • 34
    • 33744976187 scopus 로고    scopus 로고
    • Lipinski, C.A., 2004a. Solubility in the design of combinatorial libraries. Chemical Analysis, vol. 163, Analysis and Purification Methods in Combinatorial Chemistry. New York, NY, USA, pp. 407-434.
  • 35
    • 33744971014 scopus 로고    scopus 로고
    • Lipinski, C.A., 2004b. Solubility in water and DMSO: Issues and potential solutions. Biotechnology: Pharmaceutical Aspects 1. Pharmaceutical Profiling in Drug Discovery for Lead Selection, pp. 93-125
  • 36
    • 0031024171 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • Lipinski C.A., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 23 (1997) 3-25
    • (1997) Adv. Drug Del. Rev. , vol.23 , pp. 3-25
    • Lipinski, C.A.1
  • 37
    • 0037153202 scopus 로고    scopus 로고
    • Structure-Activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)-5-{2-[(3-substituted)-1-azetidinyl]ethyl}-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptor
    • MacKenzie A.R., et al. Structure-Activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)-5-{2-[(3-substituted)-1-azetidinyl]ethyl}-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptor. J. Med. Chem. 45 (2002) 5365-5377
    • (2002) J. Med. Chem. , vol.45 , pp. 5365-5377
    • MacKenzie, A.R.1
  • 38
    • 0035031472 scopus 로고    scopus 로고
    • In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery
    • Masimirembwa C.M., et al. In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery. Combinat. Chem. High Throughput Screen. 4 (2001) 245-263
    • (2001) Combinat. Chem. High Throughput Screen. , vol.4 , pp. 245-263
    • Masimirembwa, C.M.1
  • 39
    • 9644278194 scopus 로고    scopus 로고
    • Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability
    • Nassar A.-E.F., et al. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability. Drug Discovery Today 9 (2004) 1020-1028
    • (2004) Drug Discovery Today , vol.9 , pp. 1020-1028
    • Nassar, A.-E.F.1
  • 40
    • 0032733974 scopus 로고    scopus 로고
    • Prediction of human clearance of 29 drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes
    • Obach R.S. Prediction of human clearance of 29 drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab. Dispos. 27 (1999) 1350-1359
    • (1999) Drug Metab. Dispos. , vol.27 , pp. 1350-1359
    • Obach, R.S.1
  • 41
    • 8444247442 scopus 로고    scopus 로고
    • Quantitative bioanalysis: an integrated approach for drug discovery and development
    • Ong V.S., et al. Quantitative bioanalysis: an integrated approach for drug discovery and development. Int. J. Mass Spectrom. 238 (2004) 139-152
    • (2004) Int. J. Mass Spectrom. , vol.238 , pp. 139-152
    • Ong, V.S.1
  • 42
    • 0042836943 scopus 로고    scopus 로고
    • Simultaneous quantitative analysis of three drugs by high-performance liquid chromatography/electrospray ionization mass spectrometry and its application to cassette in vitro metabolic stability studies
    • Rajanikanth M., et al. Simultaneous quantitative analysis of three drugs by high-performance liquid chromatography/electrospray ionization mass spectrometry and its application to cassette in vitro metabolic stability studies. Rapid Commun. Mass Spectrom. 17 (2003) 2063-2070
    • (2003) Rapid Commun. Mass Spectrom. , vol.17 , pp. 2063-2070
    • Rajanikanth, M.1
  • 43
    • 13244282956 scopus 로고    scopus 로고
    • Automation and robotics in ADME screening
    • Saunders K.C. Automation and robotics in ADME screening. Drug Discovery Today: Technol. 1 (2004) 373-380
    • (2004) Drug Discovery Today: Technol. , vol.1 , pp. 373-380
    • Saunders, K.C.1
  • 44
    • 0034890106 scopus 로고    scopus 로고
    • Optimization of metabolic stability as a goal of modern drug design
    • Thompson T.N. Optimization of metabolic stability as a goal of modern drug design. Med. Res. Rev. 21 (2001) 412-449
    • (2001) Med. Res. Rev. , vol.21 , pp. 412-449
    • Thompson, T.N.1
  • 45
    • 0036112196 scopus 로고    scopus 로고
    • Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries
    • Xu R., et al. Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries. J. Am. Soc. Mass Spectrom. 13 (2002) 155-165
    • (2002) J. Am. Soc. Mass Spectrom. , vol.13 , pp. 155-165
    • Xu, R.1
  • 46
    • 19944427171 scopus 로고    scopus 로고
    • Simple strategies for reducing sample loads in in vitro metabolic stability high-throughput screening experiments: A comparison between traditional, two-time-point and pooled sample analyses
    • Zhao S.X., et al. Simple strategies for reducing sample loads in in vitro metabolic stability high-throughput screening experiments: A comparison between traditional, two-time-point and pooled sample analyses. J. Pharmaceut. Sci. 94 (2005) 38-45
    • (2005) J. Pharmaceut. Sci. , vol.94 , pp. 38-45
    • Zhao, S.X.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.